Anavex Life Sciences Corp (AVXL)

[falconer66a]

Who’ya gonna believe?

Oh yes, over 90% of the AD trial participants continued on into the 96 week extension part of that trial...and that data will be part of the approval request package. Additionally, those patients who have even completed that 96 weeks of extra dosing have asked and received the drug beyond that 96 week period and are now headed for 144 weeks or whatever. That seems to indicate the drug is giving them some benefit - at least enough to justify the extreme difficulty of taking a pill once a day!

But, what could those Alzheimer’s patients actually know? They’ve got Alzheimer’s disease, so they can’t possibly know that the pill they’ve been taking each day actually can’t or doesn’t work. They, or their caregivers, haven’t read what the real experts on this message board have been claiming. Blarcamesine doesn’t and can’t work. Period.